This segment focuses on the research, development, manufacturing, and distribution of infusion products. These include a variety of intravenous solutions in soft bag, plastic and glass bottle, and other packaging formats. R&D activities involve improving the safety, efficacy, and stability of infusion products, as well as developing new formulations and delivery systems. Technologies used include advanced sterile manufacturing processes and quality control systems. The therapeutic areas covered are broad, supporting patient needs in areas such as fluid and electrolyte balance, nutrition, and drug delivery. The patient impact is significant, as these products are essential for hospital care and critical medical interventions. Market positioning is strong due to the company's established manufacturing capabilities and distribution network. Future opportunities include expanding the product portfolio and exploring new markets. Regulatory and clinical aspects are critical, with adherence to stringent quality standards and clinical trials to ensure product safety and efficacy.

This segment concentrates on the development, manufacturing, and commercialization of drugs for cardiovascular and cerebrovascular diseases. The company produces a range of products, including tablets and capsules, to treat conditions such as hypertension and hyperlipidemia. R&D efforts focus on discovering and developing new drug formulations, improving existing therapies, and conducting clinical trials to demonstrate efficacy and safety. Technologies employed include advanced drug formulation techniques and analytical methods for quality control. The therapeutic areas covered include cardiology and neurology, addressing significant unmet medical needs. The patient impact is substantial, as these drugs help manage chronic conditions and prevent serious health complications. Market positioning is competitive, with a focus on providing high-quality, affordable medications. Future opportunities include expanding the product pipeline and exploring new therapeutic areas. Regulatory and clinical aspects are crucial, with rigorous testing and approval processes to ensure patient safety and efficacy.

This segment is dedicated to the development, manufacturing, and distribution of drugs for pediatric and endocrinology applications. The company offers a range of products, including compound amino acid injections for pediatrics and other drugs to treat endocrine disorders. R&D activities involve the formulation of age-appropriate medications, clinical trials to assess efficacy and safety in pediatric populations, and the development of innovative delivery systems. Technologies used include advanced pharmaceutical manufacturing techniques and rigorous quality control processes. The therapeutic areas covered include pediatrics and endocrinology, addressing critical health needs in children and patients with hormonal imbalances. The patient impact is significant, as these drugs improve the health and well-being of children and patients with endocrine disorders. Market positioning is focused on providing high-quality, specialized medications. Future opportunities include expanding the product portfolio and exploring new therapeutic areas. Regulatory and clinical aspects are critical, with stringent requirements for pediatric drug development and approval.